PCR

Syndromic Multiplex Panels Market Research Report 2024: Global Analysis, Strategies, Trends and Forecasts to 2028 with Executive Guides - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Medical Supplies, Medical Devices, Health, Technology, Infectious Diseases, Health Technology, PCR, Disease, POCT, SARS-CoV-2, RSV, DTC, BioMérieux, STI, Live

5.2.3 Infectious Disease is Declining But..

Key Points: 
  • 5.2.3 Infectious Disease is Declining But..
    5.2.5 Economic Growth improves Living Standards.
  • 5.3.14 Syndromics drives POCT adoption.
  • 6.2 BioMerieux Submits Application for Respiratory, Sore Throat Panel
    6.8 Altratech to Enter MDx, POC Space by Supplanting PCR
    6.21 Quidel Gains CE Mark for Savanna Analyzer, Respiratory Panel
    6.26 Binx Health Targeting Clinics, DTC & OTC With STI Tests
    6.27 Luminex Lands BARDA Grant to Develop Test for SARS-CoV-2, Flu, RSV
    6.29 MiRxes Receives Approval for Multiplex SARS-CoV-2, Flu Test

Xcell Biosciences Announces New Scientific and Business Advisory Board

Retrieved on: 
Wednesday, March 27, 2024
Biotechnology, Technology, Health, General Health, Oncology, Health Technology, Research, Software, Artificial Intelligence, Genetics, Science, PCR, Organization, EWF, Prostate cancer, Juno Therapeutics, Synthetic biology, Trex, University, CBO, Jak, Biology, Bayer, Investment, Therapy, Mountaineering, Intergalactic, AVATAR, SUGEN, Hematology, Bio-Rad Laboratories, Medicine

Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry.

Key Points: 
  • Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry.
  • The board will provide valuable expertise to help the company achieve its goals in the therapeutics market.
  • Prior to Affini-T, Jak was head of health venture investments for Leaps by Bayer, a leading corporate venture fund.
  • Jak also served as CEO of CytoSen Therapeutics, where he developed natural killer immune cell therapies for oncology indications.

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report 2024-2030: Growing Prevalence of Target Diseases & Increasing External Funding for R&D Fueling Expansion - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024
Health, Biotechnology, Candidiasis, Diagnosis, PCR, MVP, Conditional sentence, Bacterial vaginosis, Prevalence, Infection, Promega, Country, Thermo Fisher Scientific, SME, Tuberculosis, Application, ISH, RT, HIV, Alzheimer's disease, Incidence, Turner syndrome, Cepheid variable, Research, Trichomoniasis, Real-time, Cancer, Death, Parkinson's disease, CDC, QIAGEN, Therapy, USD, Horvitz–Thompson estimator, Helix, DSM-IV codes, Vaccine

Advancements in molecular diagnostic technology enabled the early detection of numerous diseases and reduced the possibility of severe economic & social burdens.

Key Points: 
  • Advancements in molecular diagnostic technology enabled the early detection of numerous diseases and reduced the possibility of severe economic & social burdens.
  • Molecular diagnostics enable early diagnosis of cancer, genetic disorders, and infectious diseases by using PCR, sequencing, & genetic technologies.
  • In addition, the increasing incidence of diseases, such as influenza A & B, is projected to drive market growth.
  • An increase in external funding to conduct clinical studies in molecular diagnostics is anticipated to fuel the market.

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Retrieved on: 
Monday, March 25, 2024
Science, Biotechnology, Research, Oncology, Health, Medical Devices, Health Technology, Genetics, PCR, Genomics, EVP, International, Biomarker, Cancer, Proteomics, MCRA, Bio-Rad Laboratories, MSRA, MSK

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA) with Memorial Sloan Kettering Cancer Center (MSK) under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer.

Key Points: 
  • Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA) with Memorial Sloan Kettering Cancer Center (MSK) under which the teams will collaborate on a development plan for diagnostic tests aimed at improving the treatment of cancer.
  • Biodesix will utilize its array of genomics, proteomics, and data mining capabilities with the aim of developing and commercializing oncology biomarker assays in collaboration with MSK .
  • “The expansion of our previous master sponsored research agreement (MSRA) into a master collaborative research agreement with MSK is a significant milestone for Biodesix and for biomarkers in oncology diagnostics.
  • Biodesix looks forward to co-developing and validating new test concepts under these agreements,” said Scott Hutton, CEO, Biodesix.

Circular Announces $10.5M in Funding to Scale First-of-its-Kind Platform for Sourcing Recycled Materials

Retrieved on: 
Monday, March 25, 2024
Manufacturing, Environment, Recycling, Sustainability, Chemicals, Plastics, Eclipse, E-commerce, PCR, Database, Ellen, Customer experience, Danone, United, ESG, United Nations, Metal, Artificial intelligence, Food, Taskrabbit, Carbon, Plastic, John Macarthur (wool pioneer), Braskem, Paper, MacArthur Foundation

Circular.co , the leading sustainable sourcing platform, secured $10.5M to expand its massive database of post-consumer recycled (PCR) materials and its accompanying platform that streamlines buying and selling of PCR materials.

Key Points: 
  • Circular.co , the leading sustainable sourcing platform, secured $10.5M to expand its massive database of post-consumer recycled (PCR) materials and its accompanying platform that streamlines buying and selling of PCR materials.
  • Circular will use the funding to grow its team, expand to additional sustainable materials, continue to add more companies and suppliers, and deepen the scale and functionality of its platform.
  • Circular handles the searching, sourcing, vetting, and onboarding process for its customers, with results in days compared to months or even years, using analog methods.
  • “Buyers transitioning to recycled materials face the typical challenges of an emerging, analog market rife with inefficiency and a lack of transparency.

United States In-Vitro Diagnostics Market Analysis 2023-2030: Technological Advancements Drive IVD Adoption, Enhancing Patient Outcomes Fueling Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Biotechnology, Baby, Maternity, Health, General Health, Health Technology, Medical Devices, Research, Hospitals, Genetics, Consumer, Science, Automation, PCR, Cardiovascular disease, Hematology, Haemophilia, Diabetes, Ageing, American Cancer Society, Tissue, Cancer, IVD, Leukemia, Workflow, Anemia, Blood, Medical device

The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.

Key Points: 
  • The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.
  • This reflects a commitment to enhancing patient care through innovative technology and positioning the United States at the forefront of the in-vitro diagnostics market.
  • Technological advancements are set to propel the United States in the in vitro diagnostics (IVD) market.
  • Instruments are predicted to be among the leading products in the United States in vitro diagnostics (IVD) market.

NEP Sweden Launches New Remote Operation Centres, Bringing Connected Broadcast Production Solutions to Region

Retrieved on: 
Thursday, March 21, 2024
eSports, Software, Networks, Entertainment, Sports, Internet, Data Management, Technology, Other Sports, Audio, Video, Other Technology, Electronic Games, PCR, SMPTE, DIVA, Media, Travel, Carbon footprint, SHL, Life, UHD, TFC, TV4, Swedish Hockey League, Engineering, Heart, Ecosystem, KDE, OB, NEP, HD, Multimedia, NEP Group

NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.

Key Points: 
  • NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.
  • View the full release here: https://www.businesswire.com/news/home/20240321734836/en/
    NEP Sweden's Remote Operation Centre (ROC) in Stockholm features five medium-sized production control rooms (PCR) and one large PCR.
  • The powerful broadcast control and networking solution empowers production teams by making IP 2110 technology fast and intuitive.
  • “There is a growing demand for connected production solutions, and we’re responding to the needs of our broadcast partners in the region by bringing the new NEP Sweden Remote Operation Centres online, applying NEP’s deep understanding and expertise of SMPTE IP 2110 infrastructure and making this innovative and environmentally sustainable solution available to our clients,” said Per de Navarro, Chief Technology Officer, NEP Sweden.

OTC/DTC Infectious Disease Diagnostics Market Strategies and Trends Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2024
Infectious Diseases, Biotechnology, Health, PCR, Channel, Infection, Country, COVID-19, Application, Lead, DTC, OTC, Immunoassay, CRISPR, Market analysis, Pharmaceutical industry

The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country.

Key Points: 
  • The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country.
  • With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis."
  • Over the Counter and Direct to Consumer diagnostics are set to help solve the pandemic problem.
  • Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.

LiveWire® Announces All-New S2 Mulholland™ Electric Performance Cruiser

Retrieved on: 
Thursday, March 21, 2024
Luxury, Automotive, Sports, Men, Other Retail, Automotive Manufacturing, Specialty, Manufacturing, Consumer, General Automotive, Retail, Environment, Transportation, Travel, Motor Sports, Other Transport, Green Technology, Other Automotive, Transport, Motorcycles, EV, Electric Vehicles, PCR, Livewire, Motorcycle, Level 2, Sale, Human, Level 1, Plastic, Torque, Multimedia, USD, CAD

As LiveWire’s performance cruiser, S2 Mulholland's design departs from traditional internal combustion motorcycles in the cruiser category—which typically celebrate the gas tank—as the electric S2 platform provided the design team with the opportunity to create a new profile and experience that prominently displays both the brake lines and wiring harness, creating a stronger connection between the human interface of the rider and motorcycle.

Key Points: 
  • As LiveWire’s performance cruiser, S2 Mulholland's design departs from traditional internal combustion motorcycles in the cruiser category—which typically celebrate the gas tank—as the electric S2 platform provided the design team with the opportunity to create a new profile and experience that prominently displays both the brake lines and wiring harness, creating a stronger connection between the human interface of the rider and motorcycle.
  • S2 Mulholland is based on LiveWire’s S2 platform, and the riding characteristics of the motorcycle demonstrate the same level of performance established with S2 Del Mar.
  • While S2 Mulholland utilizes the same S2 platform, the riding experience has been reshaped by the rider triangle and updated standard equipment which diverges dramatically from Del Mar.
  • The introduction of the new electric performance cruiser, S2 Mulholland, will be limited to the U.S. and Canada for 2024, with deliveries for additional markets currently planned for 2025.

Global Immune Thrombocytopenia Drug Market Report 2024 with Analysts' Recommendations - Collaboration Initiatives with Healthcare Providers and Amplify Development of IV Drugs for Chronic Applications - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024
Biotechnology, Pharmaceutical, Health, Hospital, TPO, Diagnosis, Research, PCR, Flow cytometry, Prevalence, Genetic testing, Disease, Porter's five forces analysis, Drug discovery, Incidence, Patient, SWOT, ITP, Autoantibody, Administration, Treatment, Rare disease, Drug development, Safety, Thrombocytopenia, Mimetic theory, USD, Marketing, Polymerase chain reaction, Ageing, Therapy, Pharmaceutical industry

The Global Immune Thrombocytopenia Drug market showcased growth at a CAGR of 21.32% during 2019-2022.

Key Points: 
  • The Global Immune Thrombocytopenia Drug market showcased growth at a CAGR of 21.32% during 2019-2022.
  • Immune Thrombocytopenia Drug Market is being propelled by rising prevalence of immune thrombocytopenia worldwide is a significant driver of the ITP drug market.
  • Technological advancements drive innovation and progress in the global Immune Thrombocytopenia Drug Market, accelerating drug discovery, development, manufacturing, and clinical practice.
  • The report analyses the Immune Thrombocytopenia Drug Market by End-User (Hospitals and Clinics, Specialty Centers, Research and Academic Institutes).